Epoch Investment Partners’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-111,052
Closed -$8.13K 314
2018
Q2
$8.13K Sell
111,052
-141,793
-56% -$9.64M 0.03% 231
2018
Q1
$16M Buy
252,845
+16,359
+7% +$977K 0.06% 202
2017
Q4
$12.1M Buy
236,486
+3,910
+2% +$204K 0.04% 214
2017
Q3
$12.2M Buy
232,576
+4,839
+2% +$243K 0.04% 218
2017
Q2
$11.6M Buy
227,737
+15,019
+7% +$743K 0.04% 215
2017
Q1
$9.45M Buy
+212,718
New +$9.15M 0.03% 221

Other funds holding CNMD

Epoch Investment Partners's CNMD Position: Q3 2018 in Review

Epoch Investment Partners sold out of CONMED (CNMD) in Q3 2018, closing a stake of 111,052 shares — an estimated $8.13K sold.

Epoch Investment Partners first reported a position in CNMD in Q1 2017 and held it in 6 quarters. The position peaked at $16M in Q1 2018. 207 funds tracked by Wall St. Rank hold CNMD as of Q3 2018.

  • Epoch Investment Partners reported no remaining CONMED position as of Q3 2018 after selling out during the quarter.
  • Epoch Investment Partners sold 111,052 CONMED shares in Q3 2018, an estimated $8.13K.
  • Epoch Investment Partners first reported a position in CONMED in Q1 2017 and held it in 6 quarters.
  • Epoch Investment Partners's CONMED position peaked at $16M in Q1 2018.
  • 207 funds tracked by Wall St. Rank held CONMED as of Q3 2018.

Based on Epoch Investment Partners's 13F filing for Q3 2018, filed 13 Nov 2018.